GXMC
IONS icon

Global X Management Company’s Ionis Pharmaceuticals IONS Stock Holding History

Global X Management Company’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$111K Buy
2,671
+233
+10% +$10.3K ﹤0.01% 993
2018
Q1 		$107K Buy
2,438
+460
+23% +$23.4K ﹤0.01% 963
2017
Q4 		$99K Buy
1,978
+485
+32% +$26.6K ﹤0.01% 857
2017
Q3 		$76K Buy
1,493
+158
+12% +$8.28K ﹤0.01% 889
2017
Q2 		$68K Buy
1,335
+429
+47% +$20K ﹤0.01% 946
2017
Q1 		$36K Buy
906
+635
+234% +$28.5K ﹤0.01% 959
2016
Q4 		$13K Buy
271
+9
+3% +$356 ﹤0.01% 1023
2016
Q3 		$10K Hold
262
– – ﹤0.01% 1007
2016
Q2 		$6K Buy
+262
New +$8.45K ﹤0.01% 916

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return